Aytu BioScience
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $15,165 | $13,888 | $15,135 | $18,452 |
Gross Profit | 9,098 | 9,186 | 10,254 | 12,806 |
EBITDA | -9,139 | 3,284 | -17,419 | 6,035 |
EBIT | -10,024 | 2,481 | -18,713 | 4,718 |
Net Income | -10,584 | 1,965 | -19,818 | 3,994 |
Net Change In Cash | 15,165 | 13,888 | 15,135 | 18,452 |
Free Cash Flow | 3,658 | -618 | 2,786 | -6,524 |
Cash | 30,025 | 32,630 | 30,952 | 18,173 |
Basic Shares | 10,036 | 19,476 | 6,791 | 8,204 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $66,382 | $65,183 | $107,399 | $96,669 |
Gross Profit | 45,831 | 49,054 | 66,632 | 50,283 |
EBITDA | -4,665 | 1,406 | -3,273 | -27,957 |
EBIT | -10,042 | -5,319 | -12,088 | -38,103 |
Net Income | -13,562 | -15,844 | -17,051 | -108,779 |
Net Change In Cash | 66,382 | 65,183 | 107,399 | 96,669 |
Free Cash Flow | -5,165 | -1,717 | -5,129 | -28,823 |
Cash | 30,952 | 20,006 | 22,985 | 19,360 |
Basic Shares | 6,279 | 5,537 | 3,339 | 1,470 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.23 |
2025-09-30 | -$0.08 |
2025-06-30 | -$2.93 |
2025-03-31 | $0.21 |
